P3 Health Partners (NASDAQ:PIII) Shares Gap Up on Insider Buying Activity

P3 Health Partners Inc. (NASDAQ:PIII – Get Rating) shares gapped up prior to trading on Wednesday after an insider bought additional shares in the company. The stock had previously closed at $3.21, but opened at $3.50. P3 Health Partners shares last traded at $3.51, with a volume of 154,345 shares.

Specifically, major shareholder Pacific Founders Ugp Chicago purchased 4,739,120 shares of the business’s stock in a transaction that occurred on Thursday, April 6th. The shares were acquired at an average price of $1.18 per share, for a total transaction of $5,592,161.60. Following the completion of the purchase, the insider now owns 104,740,954 shares in the company, valued at approximately $123,594,325.72. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, major shareholder Pacific Founders Ugp Chicago acquired 4,739,120 shares of the business’s stock in a transaction on Thursday, April 6th. The shares were purchased at an average price of $1.18 per share, for a total transaction of $5,592,161.60. Following the completion of the purchase, the insider now directly owns 104,740,954 shares of the company’s stock, valued at approximately $123,594,325.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Atul Kavthekar acquired 18,868 shares of the business’s stock in a transaction on Monday, May 15th. The shares were purchased at an average price of $2.65 per share, for a total transaction of $50,000.20. Following the purchase, the chief financial officer now directly owns 18,868 shares of the company’s stock, valued at $50,000.20. The disclosure for this purchase can be found here. Insiders purchased 4,956,213 shares of company stock valued at $6,197,694 over the last quarter. Company insiders own 23.60% of the company’s stock.

P3 Health Partners Price Performance

The business has a fifty day moving average of $1.35 and a 200-day moving average of $2.19. The company has a debt-to-equity ratio of 16.13, a current ratio of 0.41 and a quick ratio of 0.41.

Hedge Funds Weigh In On P3 Health Partners

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PIII. JPMorgan Chase & Co. purchased a new stake in shares of P3 Health Partners during the first quarter worth $90,000. BlackRock Inc. acquired a new stake in shares of P3 Health Partners in the first quarter valued at about $1,157,000. Vanguard Group Inc. lifted its stake in shares of P3 Health Partners by 13.5% in the first quarter. Vanguard Group Inc. now owns 2,430,062 shares of the company’s stock valued at $19,003,000 after buying an additional 289,504 shares during the period. Northern Trust Corp bought a new stake in shares of P3 Health Partners in the first quarter valued at about $162,000. Finally, State Street Corp bought a new stake in shares of P3 Health Partners in the first quarter valued at about $272,000. 51.19% of the stock is owned by institutional investors.

P3 Health Partners Company Profile

(Get Rating)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc is based in Henderson, Nevada.